5-Azacytidine is a cytidine analogue that is capable of activating repressed genes in tissue-culture cells and has been shown to increase hemoglobin-F production in anemic baboons. This drug was administered to a patient with severe beta-thalassemia in an attempt to stimulate hemoglobin-F production. After seven days of 5-azacytidine treatment, gamma-globin synthesis increased approximately sevenfold, temporarily normalizing the patient's unbalanced globin synthesis. Erythropoiesis became more effective, leading to a temporary increase in the absolute reticulocyte count (from 5000 to 22,000 per cubic millimeter) and in hemoglobin concentration (from 8.0 to 10.8 g per deciliter). Hypomethylation of bone-marrow DNA near both the gamma-globin and epsilon-globin genes was directly demonstrated. At the time of peak drug effect, about 7000 gamma-globin messenger RNA molecules were present per erythroid bone-marrow cell, in contrast to 10 to 15 epsilon-globin messenger RNA molecules per cell. 5-Azacytidine selectivity increases gamma-globin synthesis and therefore provides a new approach to the treatment of severe beta-thalassemia. Further studies will be required to evaluate the efficacy, risks, and long-term toxicity of 5-azacytidine (or related compounds) before this approach can be used as a therapy for patients with disorders of hemoglobin synthesis.
This article has been cited by other articles:
Piekarz, R. L., Bates, S. E.
(2009). Epigenetic Modifiers: Basic Understanding and Clinical Development. Clin. Cancer Res.
15: 3918-3926
[Abstract][Full Text]
Lavelle, D., Saunthararajah, Y., DeSimone, J.
(2008). DNA methylation and mechanism of action of 5-azacytidine. Blood
111: 2485-2485
[Full Text]
Mabaera, R., Greene, M. R., Richardson, C. A., Conine, S. J., Kozul, C. D., Lowrey, C. H.
(2008). Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin. Blood
111: 411-420
[Abstract][Full Text]
Chui, D. H. K.
(2007). THAL for THAL?. Blood
110: 2788-2789
[Full Text]
Mabaera, R., Richardson, C. A., Johnson, K., Hsu, M., Fiering, S., Lowrey, C. H.
(2007). Developmental- and differentiation-specific patterns of human {gamma}- and {beta}-globin promoter DNA methylation. Blood
110: 1343-1352
[Abstract][Full Text]
He, Z., Russell, J. E.
(2007). Dynamic posttranscriptional regulation of {epsilon}-globin gene expression in vivo. Blood
109: 795-801
[Abstract][Full Text]
Kransdorf, E. P., Wang, S. Z., Zhu, S. Z., Langston, T. B., Rupon, J. W., Ginder, G. D.
(2006). MBD2 is a critical component of a methyl cytosine-binding protein complex isolated from primary erythroid cells. Blood
108: 2836-2845
[Abstract][Full Text]
Rupon, J. W., Wang, S. Z., Gaensler, K., Lloyd, J., Ginder, G. D.
(2006). Methyl binding domain protein 2 mediates {gamma}-globin gene silencing in adult human betaYAC transgenic mice. Proc. Natl. Acad. Sci. USA
103: 6617-6622
[Abstract][Full Text]
Fathallah, H., Atweh, G. F.
(2006). Induction of Fetal Hemoglobin in the Treatment of Sickle Cell Disease. ASH Education Book
2006: 58-62
[Abstract][Full Text]
Blau, C. A., Barbas, C. F. III, Bomhoff, A. L., Neades, R., Yan, J., Navas, P. A., Peterson, K. R.
(2005). {gamma}-Globin Gene Expression in Chemical Inducer of Dimerization (CID)-dependent Multipotential Cells Established from Human {beta}-Globin Locus Yeast Artificial Chromosome ({beta}-YAC) Transgenic Mice. J. Biol. Chem.
280: 36642-36647
[Abstract][Full Text]
Sullivan, M., Hahn, K., Kolesar, J. M.
(2005). Azacitidine: A novel agent for myelodysplastic syndromes. Am J Health Syst Pharm
62: 1567-1573
[Abstract][Full Text]
Kaminskas, E., Farrell, A., Abraham, S., Baird, A., Hsieh, L.-S., Lee, S.-L., Leighton, J. K., Patel, H., Rahman, A., Sridhara, R., Wang, Y.-C., Pazdur, R.
(2005). Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes. Clin. Cancer Res.
11: 3604-3608
[Abstract][Full Text]
Perrine, S. P.
(2005). Fetal Globin Induction--Can It Cure {beta} Thalassemia?. ASH Education Book
2005: 38-44
[Abstract][Full Text]
Gilbert, J., Gore, S. D., Herman, J. G., Carducci, M. A.
(2004). The Clinical Application of Targeting Cancer through Histone Acetylation and Hypomethylation. Clin. Cancer Res.
10: 4589-4596
[Abstract][Full Text]
Haynes, J. Jr, Baliga, B. S., Obiako, B., Ofori-Acquah, S., Pace, B.
(2004). Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of the L-arginine-nitric oxide signaling pathway. Blood
103: 3945-3950
[Abstract][Full Text]
Dowell, J. E., Minna, J. D.
(2004). Cancer Chemotherapy Targeted at Reactivating the Expression of Epigenetically Inactivated Genes. JCO
22: 1353-1355
[Full Text]
Kozar, K., Kaminski, R., Switaj, T., Oldak, T., Machaj, E., Wysocki, P. J., Mackiewicz, A., Lasek, W., Jakobisiak, M., Golab, J.
(2003). Interleukin 12-based Immunotherapy Improves the Antitumor Effectiveness of a Low-Dose 5-Aza-2'-Deoxycitidine Treatment in L1210 Leukemia and B16F10 Melanoma Models in Mice. Clin. Cancer Res.
9: 3124-3133
[Abstract][Full Text]
Sigalotti, L., Altomonte, M., Colizzi, F., Degan, M., Rupolo, M., Zagonel, V., Pinto, A., Gattei, V., Maio, M., Lubbert, M., Wijermans, P. W., Jones, P. A., Hellstrom-Lindberg, E.
(2003). 5-Aza-2'-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach?. Blood
101: 4644-4646
[Full Text]
Segura-Pacheco, B., Trejo-Becerril, C., Perez-Cardenas, E., Taja-Chayeb, L., Mariscal, I., Chavez, A., Acuna, C., Salazar, A. M., Lizano, M., Duenas-Gonzalez, A.
(2003). Reactivation of Tumor Suppressor Genes by the Cardiovascular Drugs Hydralazine and Procainamide and Their Potential Use in Cancer Therapy. Clin. Cancer Res.
9: 1596-1603
[Abstract][Full Text]
Liu, Y., Song, J., Liu, W., Wan, Y., Chen, X., Hu, C.
(2003). Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation?. Cardiovasc Res
58: 460-468
[Abstract][Full Text]
Vadolas, J., Wardan, H., Orford, M., Voullaire, L., Zaibak, F., Williamson, R., Ioannou, P. A.
(2002). Development of sensitive fluorescent assays for embryonic and fetal hemoglobin inducers using the human beta -globin locus in erythropoietic cells. Blood
100: 4209-4216
[Abstract][Full Text]
Goffin, J., Eisenhauer, E.
(2002). DNA methyltransferase inhibitors--state of the art. Ann Oncol
13: 1699-1716
[Abstract][Full Text]
He, Z., Russell, J. E.
(2002). A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease. Proc. Natl. Acad. Sci. USA
99: 10635-10640
[Abstract][Full Text]
Silverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., Ellerton, J., Larson, R. A., Schiffer, C. A., Holland, J. F.
(2002). Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B. JCO
20: 2429-2440
[Abstract][Full Text]
Koshy, M., Dorn, L., Bressler, L., Molokie, R., Lavelle, D., Talischy, N., Hoffman, R., van Overveld, W., DeSimone, J.
(2000). 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia. Blood
96: 2379-2384
[Abstract][Full Text]
Skarpidi, E., Vassilopoulos, G., Li, Q., Stamatoyannopoulos, G.
(2000). Novel in vitro assay for the detection of pharmacologic inducers of fetal hemoglobin. Blood
96: 321-326
[Abstract][Full Text]
Smith, R. D., Li, J., Noguchi, C. T., Schechter, A. N.
(2000). Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells. Blood
95: 863-869
[Abstract][Full Text]
Olivieri, N. F.
(1999). The {beta}-Thalassemias. NEJM
341: 99-109
[Full Text]
Singal, R., Ginder, G. D.
(1999). DNA Methylation. Blood
93: 4059-4070
[Full Text]
Atweh, G. F., Sutton, M., Nassif, I., Boosalis, V., Dover, G. J., Wallenstein, S., Wright, E., McMahon, L., Stamatoyannopoulos, G., Faller, D. V., Perrine, S. P.
(1999). Sustained Induction of Fetal Hemoglobin by Pulse Butyrate Therapy in Sickle Cell Disease. Blood
93: 1790-1797
[Abstract][Full Text]
Ikuta, T., Kan, Y. W., Swerdlow, P. S., Faller, D. V., Perrine, S. P.
(1998). Alterations in Protein-DNA Interactions in the gamma -Globin Gene Promoter in Response to Butyrate Therapy. Blood
92: 2924-2933
[Abstract][Full Text]
Hossain, M. Md., Nakayama, H., Goto, N.
(1995). Apoptosis in the Central Nervous System of Developing Mouse Fetuses from 5-Azacytidine-Administered Dams. Toxicol Pathol
23: 367-372
[Abstract]
Lowrey, C. H., Nienhuis, A. W.
(1993). Treatment with Azacitidine of Patients with End-Stage {beta}-Thalassemia. NEJM
329: 845-848
[Full Text]
Perrine, S. P., Ginder, G. D., Faller, D. V., Dover, G. H., Ikuta, T., Witkowska, H. E., Cai, S.-p., Vichinsky, E. P., Olivieri, N. F.
(1993). A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the {beta}-Globin Disorders. NEJM
328: 81-86
[Abstract][Full Text]
Kim, C G, Epner, E M, Forrester, W C, Groudine, M
(1992). Inactivation of the human beta-globin gene by targeted insertion into the beta-globin locus control region.. Genes Dev.
6: 928-938
[Abstract]
SANDS, J. M., MACHER, A. M., LEY, T. J., NIENHUIS, A. W.
(1985). Disseminated Infection Caused by Cunninghamella bertholletiae in a Patient with Beta-Thalassemia: Case Report and Review of the Literature. ANN INTERN MED
102: 59-63
[Abstract]
Papayannopoulou, T, Torrealba de Ron, A, Veith, R, Knitter, G, Stamatoyannopoulos, G
(1984). Arabinosylcytosine induces fetal hemoglobin in baboons by perturbing erythroid cell differentiation kinetics. Science
224: 617-619
[Abstract]
SHAPIRO, J. R., ROWE, D. W.
(1983). Collagen Genes and Brittle Bones. ANN INTERN MED
99: 700-704
[Abstract]
Ikuta, T., Ausenda, S., Cappellini, M. D.
(2001). Mechanism for fetal globin gene expression: Role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. Proc. Natl. Acad. Sci. USA
98: 1847-1852
[Abstract][Full Text]
Sabatino, D. E., Seidel, N. E., Aviles-Mendoza, G. J., Cline, A. P., Anderson, S. M., Gallagher, P. G., Bodine, D. M.
(2000). Long-term expression of gamma -globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma -globin gene fused to the ankyrin-1 promoter. Proc. Natl. Acad. Sci. USA
97: 13294-13299
[Abstract][Full Text]
